More consistent antilipolitic and antiketogenetic action of insulin Glargine U300 vs U100 in type 1 diabetes

被引：0
|
作者：
Lucidi, P. [1 ]
Candeloro, P. [1 ]
Andreoli, A. Marinelli [1 ]
Cioli, P. [1 ]
Bolli, G. B. [1 ]
Fanelli, C. G. [1 ]
Porcellati, F. [1 ]
机构：
[1] Univ Perugia, Internal Med, Perugia, Italy
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
673
引用
收藏
页码：S307 / S307
页数：1
相关论文
共 50 条
  • [41] Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
    Rosenstock, Julio
    Gowda, Amoolya
    Liang, Bo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (16): : 1532 - 1533
  • [42] Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
    Rosenstock, Julio
    Bain, Stephen C.
    Gowda, Amoolya
    Jodar, Esteban
    Liang, Bo
    Lingvay, Ildiko
    Nishida, Tomoyuki
    Trevisan, Roberto
    Mosenzon, Ofri
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (04): : 297 - 308
  • [43] In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
    Schiavon, Michele
    Visentin, Roberto
    Giegerich, Clemens
    Sieber, Jochen
    Dalla Man, Chiara
    Cobelli, Claudio
    Klabunde, Thomas
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (08) : 553 - 561
  • [44] Effects of Switching from Degludec to Glargine U300 in Patients with Insulin-Dependent Type 1 Diabetes: A Retrospective Study
    Sawamura, Toshitaka
    Karashima, Shigehiro
    Ohbatake, Azusa
    Higashitani, Takuya
    Ohmori, Ai
    Sawada, Kei
    Yamamoto, Rika
    Kometani, Mitsuhiro
    Katsuda, Yuko
    Yoneda, Takashi
    [J]. MEDICINA-LITHUANIA, 2024, 60 (03):
  • [45] Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes The SWITCH 2 Randomized Clinical Trial
    Wysham, Carol
    Bhargava, Anuj
    Chaykin, Louis
    de la Rosa, Raymond
    Handelsman, Yehuda
    Troelsen, Lone N.
    Kvist, Kajsa
    Norwood, Paul
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (01): : 45 - 56
  • [46] COST-UTILITY ANALYSIS OF INSULIN DEGLUDEC VS. INSULIN GLARGINE U100 TREATMENT IN PATIENTS WITH DIABETES MELLITUS TYPE 1 AND 2 IN SERBIA
    Culic, M.
    Russel-Szymczyk, M.
    Chubb, B.
    Tikkanen, C.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A674 - A674
  • [47] Effect of insulin degludec vs insulin glargine U100 on continuous glucose monitoring recorded metrics in people with type 1 diabetes and nocturnal severe hypoglycaemia
    Brosen, J. M. B.
    Agesen, R. M.
    Alibegovic, A. C.
    Andersen, H. U.
    Gustenhoff, P.
    Hansen, T. K.
    Hedetoft, C.
    Jensen, T. J.
    Juhl, C. B.
    Stolberg, C. R.
    Lerche, S. S.
    Norgaard, K.
    Parving, H. -H.
    Tarnow, L.
    Pedersen-Bjergaard, U.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S330 - S331
  • [48] Lower pharmacokinetic and pharmacodynamic within-day variability of individual clinical doses of insulin glargine 300 U/ml vs glargine 100 U/ml in type 1 diabetes
    Fanelli, C. G.
    Lucidi, P.
    Candeloro, P.
    Cioli, P.
    Andreoli, A. Marinelli
    Bolli, G. B.
    Porcellati, F.
    [J]. DIABETOLOGIA, 2018, 61 : S409 - S409
  • [49] Glycaemic variability and risk for hypoglycaemia on insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes
    Kovatchev, B.
    Meng, Z.
    Breton, M.
    Leroy, B.
    Cali, A.
    Perfetti, R.
    [J]. DIABETOLOGIA, 2017, 60 : S36 - S37
  • [50] Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria
    Monika Russel-Szymczyk
    Vasil Valov
    Alexandra Savova
    Manoela Manova
    [J]. BMC Endocrine Disorders, 19
12345